To further investigate the effects of TBX15 expression on DOX sensitivity, we utilized two DOX-resistant breast cancer cell lines, MCF7/ADR, and T47D/ADR, and treated these cells with varying concentrations of DOX. Here, TBX15 is linked to breast carcinoma.